Stocks · News reference
Morgan Stanley Maintains Underweight on Helmerich & Payne, Raises Price Target to $41
Morgan Stanley analyst Joe Laetsch maintains Helmerich & Payne (NYSE:HP) with a Underweight and raises the price target from $36 to $41.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
'Trump’s Venezuelan Oil Company Plans Massive Drilling Push; Company Led By Alejandro Betancourt Plans To Dispatch More Than 50 Drilling Rigs To Turbocharge The Country’s Anemic Crude Production' - WSJ Exclusive
https://www.wsj.com/business/energy-oil/trumps-venezuelan-oil-company-plans-massive-drilling-push-db439e19
Ascendis Pharma, Science Applications International And Other Big Stocks Moving Higher On Monday
U.S. stocks were lower, with the Dow Jones index falling around 400 points on Monday. Shares of Ascendis Pharma A/S (NASDAQ:ASND) rose sharply on Monday. On Sunday, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)